News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-04-20 4:31:1 am Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday InvestorPlace
2023-04-10 5:45:0 am Over 100 Patients Now Enrolled in CNS Pharmaceuticals’ (NASDAQ: CNSP) Potentially Pivotal Study Evaluating Berubicin for the Treatment of Glioblastoma Multiforme (GBM) ACCESSWIRE
2023-04-06 6:5:0 am CNS Pharmaceuticals Receives Approval from Competent Authority and Central Ethics Committee in Italy for Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM ACCESSWIRE
2023-04-03 5:5:0 am CNS Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate Update ACCESSWIRE
2023-03-29 6:5:0 am CNS Pharmaceuticals to Present at the Virtual Investor GBM Spotlight Event PR Newswire
2023-03-13 4:5:0 am CNS Pharmaceuticals Announces it Has No Exposure to Silicon Valley Bank Issues PR Newswire
2023-03-09 6:5:0 am CNS Pharmaceuticals Continues Momentum in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM with First Patient Enrolled in Switzerland PR Newswire
2023-02-07 5:45:0 am CNS Pharmaceuticals Announces First Patient Enrolled in Spain in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM PR Newswire
   

Please consider a small donation if you think this website provides you with relevant information